DCRM-OX Dual-Acting Calorie Restriction Mimetic Optimized Xtract
Indications for anti-obesity and anti-aging, as well as anti-oxidation research
47 Item Items
In Stock
Warning: Last items in stock!
Availability date:
DCRM-OX
DCRM-OX Dual-Acting Calorie Restriction Mimetic Optimized Xtract
Indications for anti-obesity and anti-aging, as well as anti-oxidation research
Recipient :
* Required fields
or Cancel
DCRM-OX Dual-Acting Calorie Restriction Mimetic Optimized Xtract
Animal Research Efficacy Highlights:
DCRM-OX demonstrates highly significant and rapid reduction in bodyweight in animal models via selective PPARalpha agonist effects and potent oxidative phosphorylation uncoupling effects.
DCRM-OX imparts effects that mimic those of calorie restriction while as well imparting appetite suppressant effects. Siginifcant antioxidant capacity was as well found within assays.
Projected Clinical Trial Theorized Optimized Protocols:
DCRM-OX, within extrapolation from animal data, is projected to have dosage arms for anti-obesity effects at 400mg and 800mg b.i.d. to produce rapid weight loss. DCRM-OX is projected to provide a non-stimulant weight loss agent with minimal adverse effect potential.
USAGE: For Research Use Only! Not For Use in Humans.